EVM
FLGT icon

Eaton Vance Management’s Fulgent Genetics FLGT Stock Holding History

Eaton Vance Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-516
Closed -$52K – 2118
2021
Q4 		$52K Buy
516
+223
+76% +$19.6K ﹤0.01% 2081
2021
Q3 		$0 Buy
293
+60
+26% +$5.45K ﹤0.01% 2243
2021
Q2 		$22K Buy
233
+116
+99% +$9.26K ﹤0.01% 2405
2021
Q1 		$11K Buy
+117
New +$12.1K ﹤0.01% 2322

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eaton Vance Management's FLGT Position: Q1 2022 in Review

Eaton Vance Management sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 516 shares — an estimated $52K sold.

Eaton Vance Management first reported a position in FLGT in Q1 2021 and held it in 4 quarters. The position peaked at $52K in Q4 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Eaton Vance Management reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 516 Fulgent Genetics shares in Q1 2022, an estimated $52K.
  • Eaton Vance Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Fulgent Genetics position peaked at $52K in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.